List view / Grid view
5 July 2022 | By Hannah Balfour (European Pharmaceutical Review)
Pfizer plans to reduce greenhouse gas emissions by 95 percent, moving away from fossil fuels to reach net-zero 10 years ahead of global target.
5 November 2020 | By Victoria Rees (European Pharmaceutical Review)
GSK will use 100 percent renewable electricity usage among other efforts in its plans to have a net zero impact on the climate by 2030.
7 June 2021 | By Hannah Balfour (European Pharmaceutical Review)
The Alliance to Zero was founded by eight pharma/biotech supply companies to promote the transition of the pharma sector to net zero emissions.
21 November 2023 | By Catherine Eckford (European Pharmaceutical Review)
The lower carbon propellant has the potential to reduce greenhouse gas emissions from Ventolin (salbutamol) inhaler by approximately 90 percent, GSK reports.
24 September 2021 | By Anna Begley (European Pharmaceutical Review)
Takeda announced the official ground-breaking of its first building to follow the Singapore Green Mark Zero Energy certification scheme.
15 September 2022 | By Hannah Balfour (European Pharmaceutical Review)
Investing in a new production facility and carbon net-zero emissions warehouse in Lessines, Belgium, Takeda aims to expand access for rare and complex chronic disease treatments.
21 May 2019 | By STERILINE S.r.l
As a single-source supplier of equipment solutions for the primary packaging of injectable drugs, Steriline develops, manufactures and supplies a comprehensive range of solutions, including both mechanical and robotic applications for the aseptic processing.
31 October 2022 | By Catherine Eckford (European Pharmaceutical Review)
A report shows two Big Pharma companies made the top 10 in the FTSE sustainability leaderboard, yet progress against climate goals has stalled since COP26.
5 November 2021 | By Anna Begley (European Pharmaceutical Review)
The biopharmaceutical industry performed significantly above average in EcoAct’s Climate Reporting Performance analysis – but what steps are big pharma companies taking to improve sustainability and how much further do they need to go?
12 January 2023 | By Catherine Eckford (European Pharmaceutical Review)
Two Big Pharma companies and one CDMO have been awarded the Terra Carta Seal, which recognises the efforts of global companies in their commitment to sustainability.
10 June 2021 | By Giacomo Chiesi (Chiesi Group)
In this article, Giacomo Chiesi from Chiesi Group outlines why the company took steps to become Benefit Corporation and B Corp certified, how this status may impact business and the associated operations.
21 September 2021 | By Anna Begley (European Pharmaceutical Review)
GSK announced multi-million renewable energy investment and low carbon inhaler programme in run-up to New York Climate Week.
19 April 2013 | By Baxter International Inc.
Baxter has reported first quarter financial results in line with the company's previously issued guidance...
21 December 2022 | By "Stefan Koenig (Roche), Jan Backmann (Roche), Martin Held (Institute of Biotechnology of the Swiss Federal Institute of Technology) ", Martin Olbrich (Roche)
Manufacturers of (bio)pharmaceuticals, medical devices and in vitro diagnostics have the opportunity to lead the way in the defossilisation of organic chemicals. Here Martin Held from the Institute of Biotechnology of the Swiss Federal Institute of Technology and Roche’s Stefan Koenig, Martin Olbrich and Jan Backmann propose how to reduce…
14 September 2023 | By Catherine Eckford (European Pharmaceutical Review)
Part of AstraZeneca's £100 million renewable energy commitment involves a 15-year partnership to establish the UK’s first unsubsidised industrial-scale supply of biomethane, supporting sustainable pharmaceutical manufacturing.
